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Abstract
Background: Diarrhea continues to be one of the most common cause 
of morbidity and mortality among infants and children in developing 
countries. This study was carried out among Libyan children hospital-
ized in Benghazi children hospital, to be investigated for the incidence 
of diarrheagenic E.coli types and antimicrobial susceptibility profiles of 
all E.coli isolates in their stool samples.
Methods and patients: A total of 200 children with diarrhea and 90 
without diarrhea were their stools investigated using culture on Mac-
Conkey agar, and the E.coli isolates were examined for detection of 
diarrheagenic E. coli types, antimicrobial susceptibility pattern, pres-
ence of integrons, ESBL-CTX-M and fluroquinolone resistance genes 
using PCR.
Results: The study has indicated that diarrheagenic E. coli isolates were 
found only in stools of children with diarrhea. The detected diarrhea-
genic E.  coli  types were the following: 4 (2%) enteroaggregative E. 
coli (EAEC), 3 (1.5%) enteroinvasive E. coli (EIEC), and 1(0.5%) entero-
hemorrhagic E. coli (EHEC), and both enterotoxigenic E. coli(ETEC) and 
enteropathogenic E. coli(EPEC) were not present. It has also found that 
multidrug resistant E.coli (> 3 drugs) was higher prevalent in com-
mensal intestinal E.coli than in diarrheagenic E.coli isolates, and both 
carried high rates of Class 1 integrons, bla(CTX-M) and fluroquinolone 
resistance genes.
Conclusion: This study revealed the low incidence of diarrheagenic 
E. coli  isolates and high prevalent of antimicrobial resistance among 
normal intestinal E.coli of hospitalized children in Benghazi/Libya.
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Introduction
Infectious diarrhea continues to be one of the most 
common cause of morbidity and mortality affect-
ing children in many developing countries. It is the 
second leading cause of death in children under 
five years old, and both Rotavirus and diarrheagen-
ic E.coli are the leading cause of diarrheal disease 
[1]. Among the bacterial pathogens, diarrheagenic 
Escherichia coli (E.coli) is an important agent of en-
demic and epidemic diarrhea worldwide and espe-
cially in developing countries [1,2].
Among the E. coli causing diarrhea, there were five 
commonly recognized types : enterotoxigenic E. coli 
(ETEC), enteropathogenic E. coli (EPEC), and en-
teroinvasive E. coli (EIEC), enteroaggregative E. coli 
(EAEC), enterohemorhagic E. coli (EHEC). Each type 
has specific virulence factors that are used for their 
identification and classification. With the exception 
of EHEC , especially E. coli 0157:H7 , diarrheagenic 
E. coli strains are not routinely detected in most 
clinical laboratories [2].
Diarrheal disease caused by E.coli are usually trans-
mitted through food or water contaminated with 
human or animal feces [3,4]. Person-to-person 
transmission might also take place, but it is probably 
less common. There are few studies from the Arab 
countries including Libya which have investigated 
the occurrence of diarrheagenic E.coli genotypes 
and their antimicrobial susceptibility profiles during 
the last 10-year [5-11].
Accurate detection and identification of diarrhea-
genic E.coli can’t be done only by culture, biochemi-
cal and serotyping tests, since they are indistinguish-
able from the non- pathogenic E.coli commonly 
found in human feces. Therefore, only DNA based 
method such as polymerase chain reaction (PCR) 
assay can be used for rapid and reliable diagnosis, 
and which has a high sensitivity and specificity for 
their detection [12,13].
The present study carried out with the aim to de-
termine the incidence of diarrhoeagenic E. coli in 
hospitalized children in Benghazi Children Hospital, 
Libya, using multiplex PCR , and to investigate the 
antimicrobial resistance profiles of commensal intes-
tinal E.coli isolates in these children.
Patients & Methods
Patients
A total of 290 stool samples were collected from 
hospitalized children in the Children Hospital of 
Benghazi, Libya, over a period of 3 months (March 
to June 2012). Of these, 200 stool samples were 
obtained from patient with diarrhea and 90 samples 
from healthy controls without diarrhea. The study 
was approved by the administration of Benghazi 
Children Hospital, Libya. An informed consent was 
obtained from parents. Data collection included the 
following: age, gender, presence or absence of wa-
tery or bloody diarrhea, fever, antibiotic treatment, 
and presence of specific associated disease.
Collection of stool samples
Stool samples were collected from children using 
a cotton swabs and these were directly inoculated 
into transport fluid medium. All samples were trans-
ferred to the microbiology laboratory for culture in 
the laboratory of Benghazi Children Hospital.
Isolation and Confirmation the identity of 
E.coli isolates
Each fresh stool sample was cultured directly on 
MacConkey agar plate (Oxoid, Basingstoke, Eng-
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land) and incubated aerobically at 37c’ for 18-24h. 
A total of 10 red colonies that morphologically sus-
pected to be E.coli were picked up and incubated 
in 1 ml brain-heart infusion broth tubes which con-
tained 25% glycerol, and the tubes were stored at 
-70Cº for further investigation. All other investiga-
tions were carried out at the Research Microbiology 
Laboratories, Faculty of Medicine, The Jordan Uni-
versity, Amman, Jordan. All collected E.coli isolates 
were identified first on basis of lactose fermentation 
on MacConkey, biochemical tests including fermen-
tation of Triple sugar iron agar test(TSI), positive in-
dole and citrate utilization test, and negative urease 
production.
Multiplex PCR reaction for detection 
Diarrheagenic E. coli
DNA extraction was performed using G-spin To-
tal DNA Extraction Kit ( INTRON Biotechnology /
Gyeonggi-do 462-807 Korea). The DNA extracts of 
investigated E.coli isolates were used after spectro-
photometric quantitation for detection of the fol-
lowing markers: eaeA (structural gene for intimin of 
EHEC and EPEC), bfpA (structural gene for EPEC), 
vt1 and/or vt2 (Shiga toxins 1 and 2 of EHEC), eltB 
and/or estA (enterotoxins of ETEC), ial (EIEC), and 
pCVD (EAEC) as described by Shehabi et al. [11]. 
The primers selected for use in the amplification 
are matched the sequences of the corresponding 
genes of EAEC, EHEC, EIEC, EPEC, and ETEC in the 
GenBank and EMBL database libraries as shown in 
Table 1.
Table 1. Primers used for detection of diarrheagenic E.coli and antimicrobial resistant genes.
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Antimicrobial Susceptibility testing
Antimicrobial susceptibility testing of E.coli isolates 
was performed by the Kirby-Bauer disk diffusion 
method on Mueller-Hinton agar medium (Oxoid, 
Basingstoke, England), MICs of 4 antimicrobials were 
determined using Etest® (BioMe r´ieux Inc., France). 
The results were interpreted according to the rec-
ommendation guidelines of the Clinical Laboratory 
and Standards Institute (CLSI,2012) (14 ). In addition, 
the isolates were investigated for presence of inte-
grons (classes I, II, and III) and antibiotic-resistance 
genes of bla(CTX-M) as reported by AbSalah et al. 
2013 [15]. The antimicrobial drugs tested are shown 
in Table 3. E. coli ATCC 25922 strain was included 
as a control in all laboratory assays.
Results
This prospective study investigated a total of 290 
hospitalized children with and without diarrhea 
(control group) aged between one month and ap-
proximately 48 months. The 200 patients with di-
arrhea included 115 (57.5%) males and 85 (42.5%) 
females divided according their age in 7 groups as 
shown in Table 2. A total of 62% of children with 
watery / bloody diarrhea and have fever were aged 
≤ one year. The control group included 90 children 
without diarrhea, of these 50 (55.6%) were females 
and 40 (44.4%) were males (Table 2).





































290 18 15 19 31 51 93 63 Total
Table 3. Distribution of diarrheagenic E.coli types in stools of 290 children.
No. (%) Children 
Diarrheagenic E. coli
Without diarrhea** With diarrhea*
0 3 (1.5) EIEC
0 1 (0.5) EHEC
0  4 (2) EAEC
0 0 EPEC
0  8 (4) Total
* 102 (51%) and ** 41(45.6% ) were on antibiotic treatment during collection of stools
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The following diarheagenic E.coli isolates were re-
covered from all examined 290 stool samples of 
children; 4 (2%) enteroaggregative E. coli (EAEC, 3 
(1.5%) enteroinvasive E. coli (EIEC), and one 1(0.5%) 
enterohemorrhagic E. coli (EHEC) (Table 3).
The antibiotic susceptibility results of the 8 diarrhea-
genic E. coli isolates are shown in Table 4. The re-
sults has shown that most of 8 diarrheagenic E.coli 
isolates were susceptible to ciprofloxacin (100%), 
cefotixin (100%), gentamycin (100%), nalidixic acid 
(100%), amikacin (87.5%), nitrofurantoin (87.5%), 
ceftazidime (75%), ceftriaxone (75%), cefotixim 
(75%), augmentin (50%) and cotrimoxazole (37.5%) 
(Table 3). The susceptibility results of the 15 non-
diarrheagenic E. coli isolates which were resistant to 
≥ 3 drugs (Multidrug Resistant; MDR) were the fol-
lowing: cefotixin (73.3%), amikacin (53.3%), genta-
mycin (40%), nitrofurantoin (40%), ceftazidime 
(33.3%), ciprofloxacin (33.3%), ceftriaxone (26.7%), 
cefotixime (26.7%), cotrimoxazole (26.7%) nalidixic 
acid (26.7%) and augmentin (6.7 %). High MICs90 
(mg/L) (10. 12 to >128 ) were observed for the fol-
lowing examined drugs; ciprofloxacin, gentamycin, 
ceftriaxone and cefotaxime, respectively (Table 4).
The distribution results of bla CTX-M genes among 
15 MDR non-diarrheagenic E.coli isolates were the 
following: CTX-M group I was found in 8(53.3%), 
CTX-M group II in 3(20%), CTX-M 15 in 9 (60%), 
CTX-M 8 and CTX-M 9 were not detected in any of 
the isolates, respectively (Table 5). While diarrhea-
genic E.coli results showed that CTX-M 8 and CTX-
M 9 were detected in 100%, CTX-M group II in 7 
(87.5%), CTX-M group I in 3 (37.5%), and CTX-M 
15 in 1 (12.5%) of the isolates, respectively ( Table 
5). Both diarrheagenic and commensal E,coli carried 
only 47% and 50% of Class I integrons, respectively 
(Table 5). The distribution of potential quinolone 
resistance genes (Gyr A, Parc) and integrons among 
Table 4.  Antimicrobial susceptibility of 15 representative MDR of commensal E.coli and 8 diarrheagenic 
E. coli isolates from stool of children*
Antibiotics
Diarrheagenic E.coli Non-diarrheagenic E.coli Non-diarrheagenic E.coli
 (%) Susceptible  (%) Susceptible MICs90 (mg/L)
Ciprofloxacin 100 33.3 10.12
Cefotixin 100 73.3 -
Gentamycin 100 40  >64
Nalidixic acid 100 26.7 -
Amikacin 87.5 53.3 -
Nitrofurantoin 87.5 40 -
Ceftazidime 75 33.3 -
Ceftriaxone 75 26.7 >32
cefotaxime 75 26.7 >128
Augmentin 50 6.7 -
Cotrimoxazole 37.5 26.7 -
*MDR accounted for 64 % of all 290 E.coli isolates
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MDR commensal E.coli isolates were the following: 
11/15 (73.3%) carried both Gyr A, Parc genes and 
7/15 (47% ) harbored Class 1 integrons, whereas 
8/8 (100%), 7/8 (87.5%) and 4/8(50%) of diarrhea-
genic E.coli isolates carried Gyr A, Parc genes and 
integrons, respectively.
Discussion
This study demonstrates that the majority of chil-
dren with watery or bloody diarrhea (62%) were 
aged less than1-year and presented with fever. 
These features are similar to many other studies 
described from the developing countries [1, 6-8-11].
The present study showed that diarrheagenic E.coli 
isolates were found only in 4 % of children with di-
arrhea and no single diarrheagenic E.coli isolate was 
detected in the control children group. The study 
also indicated the presence of (EAEC), (EIEC) and 
(EHEC), whereas the two types (EPEC and ETEC) 
were not detected in any child (Table 3). The pres-
ence rate of EAEC among diarrheal cases in this 
study is much similar to studies recently reported 
from Libya, Egypt and Iran [5,6,16-17], but in con-
trast to the other studies carried out in Kuwait and 
Jordan which had shown that EAEC was not a cause 
of diarrhea in their examined pediatric population 
[8,11]. However, the absence or low occurrence rate 
of EIEC (1.5%) in diarrhea cases and controls in this 
study is similar to the results of other reported stud-
ies from Egypt, Kuwait and Jordan [6,8,11]. In addi-
tion, it is important to note here that about half of 
the examined children were on antibiotic treatment 
during collection of their stool samples, and this 
might has been interfered with rate of recovery of 
diarrheagenic E.coli.
The results of this study showed high rates of an-
timicrobial resistance (24-93%) to many antimicro-
bial classes, including 3-generation cephasporines 
(Ceftazidim, ceftriaxone, cefotixime ), and MDR 
E.coli accounted for 64% of all isolates (Table 4). 
All MDR commensal intestinal and diarrheagenic 
E.coli isolates carried various resistance rates (12-
100%) bla(CTX-M) genes, and particularly CTXM-
15 found more frequently in commensal intestinal 
E.coli than diarrheagenic E.coli isolates (60% versus 
12.5%). These results are similar to some extend 
Table 5.  Distribution of integrons, genes of bla(CTX-M) , and fluoroquinolone resistance (Gyr A and Par 
C) in diarrheagenic E.coli and multidrug resistant of commensal E.coli isolates
No.(%) of 8 Diarrheagenic  
E.coli isolates
No.(%) of 15 Multidrug resistant 
 commensal E.coli isolates 
Genes 
3 (37.5) 8 (53.3) CTX-M I
7 (87.5) 3 (20) CTX-M II
8 (100) Null CTX-M 8
8 (100) Null CTX-M 9
1 (12.5) 9 (60) CTX-M 15
4(50) 7 (47) Class 1 integrons
8 (100) 11 (73.3) Gyr A gene
7 (87.5) 11 (73.3) Par c gene 
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to many recent studies carried out in other Arabic 
countries [15,18-21]. Over the past ten years, the 
bla(CTX-M) genes have become the most preva-
lent ESBLs among multidrug resistant organisms 
worldwide, started first in certain countries of Eu-
rope and South America, and later spread to India 
China, and other countries[ 15, 18,19, 21,23, 24]. 
In addition, this study showed high rates of Class I 
integrons in both MDR intestinal commensal E.coli 
and diarrheagenic E.coli isolates (73-100%) which 
carried one or both potential fl uroquinolone resist-
ance genes (gyrA and parC) (Table 5). It has been 
previously established that high prevalence of Class 
I integrons contributes to increase the development 
of MDR in Enterobacteriaceae and particularly in fe-
cal E.coli [25- 27]. Also, fluoroquinolone resistance 
in E. coli represents a substantial threat among com-
munity patients, since these drugs are increasingly 
used in empirical therapy of urinary tract and other 
infections [28-29].
In conclusion, diarrheagic E.coli types are not widely 
detected as cause of diarrhea in Libyan children of 
Benghazi , whereas high rates of normal intestinal 
E. coli isolates from children were MDR, carried bla-
CTX-M , Class I integrons and potential fluroquino-
lone resistance genes. This study confi rms the ur-
gent need to monitor antimicrobial resistance trends 
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